Skip to Main Content

Joseph Kim, MD

Associate Professor of Internal Medicine (Medical Oncology)

Contact Information

Joseph Kim, MD

Patient Care Location

Mailing Address

  • 25 York Street

    PO Box 208028

    New Haven, CT, 06520-8028

    United States



Dr. Joseph Kim received his medical oncology fellowship training at National Cancer Institute, NIH, where he received training in development of clinical trials of novel cancer therapies for genitourinary cancers and other solid tumors. He is also a recipient of several awards, including Young Investigator Award by Conquer Cancer Foundation, American Society of Clinical Oncology (ASCO). Dr. Kim specializes in early phase clinical trials of novel cancer therapies and in caring for patients with prostate cancer, urinary tract and bladder cancer, penile cancer, testicular cancer, and other genitourinary malignancies. Dr. Kim research interest include DNA repair pathway, mTOR pathway, tumor hypoxia, cancer immunotherapy. Dr. Kim is currently spearheading several NCI-sponsored clinical trials of PARP inhibitor, olaparib in combination with a VEGFR tyrosine kinase inhibitor, cediranib, in prostate cancer (CTEP# 9984) and in other advanced solid tumors (CTEP #9881) as well as a mTOR inhibitor, sapanisertib (aka TAK228 or MLN0128) for advanced urinary tract cancers (CTEP #9767) as the Study Chair. He is an active member of Society of Immunotherapy of Cancer, AACR and ASCO.

Education & Training

  • MD
    Wake Forest University School of Medicine (2007)
  • Fellow
    National Institutes of Health
  • Resident
    Emory University School of Medicine
  • Board Certification
    AB of Internal Medicine, Internal Medicine (2010)

Honors & Recognition

AwardAwarding OrganizationDate
Young Investigator AwardConquer Cancer Foundation, American Society of Clinical Oncology2013
Merit AwardConqer Cancer Foundation, American Society of Clinical Oncology2013

Departments & Organizations